Abstract
Sepsis is a host's deleterious response to infection, which could lead to life-threatening organ dysfunction. Sepsis-associated acute kidney injury (SA-AKI) is the most frequent organ dysfunction and is associated with increased morbidity and mortality. Sepsis contributes to ≈50% of all AKI in critically ill adult patients. A growing body of evidence has unveiled key aspects of the clinical risk factors, pathobiology, response to treatment and elements of renal recovery that have advanced our ability to detect, prevent and treat SA-AKI. Despite these advancements, SA-AKI remains a critical clinical condition and a major health burden, and further studies are needed to diminish the short and long-term consequences of SA-AKI. We review the current treatment standards and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management of SA-AKI.
| Original language | English |
|---|---|
| Pages (from-to) | 26-35 |
| Number of pages | 10 |
| Journal | Nephrology Dialysis Transplantation |
| Volume | 39 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2024 |
| Externally published | Yes |
Keywords
- acute kidney injury
- biomarker
- renal replacement therapy
- sepsis
Fingerprint
Dive into the research topics of 'Sepsis-associated acute kidney injury - treatment standard'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver